comparemela.com
Home
Live Updates
Lysyl Oxidase Like 2 Inhibitor - Breaking News
Pages:
Latest Breaking News On - Lysyl oxidase like 2 inhibitor - Page 1 : comparemela.com
GB2064 Displays Preliminary Efficacy, Tolerability in Myelofibrosis
The potential first-in-class, oral, lysyl oxidase-like 2 inhibitor GB2064 displayed efficacy with a generally acceptable tolerability profile in the treatment of patients with myelofibrosis.
City of
United kingdom
Claire harrison
Hanst schambye
Dynamic international prognostic scoring
Galecto inc
Safety review committee
Total symptom score
Phase 2a mylox 1 trial nct04679870
Lysyl oxidase like 2 inhibitor
vimarsana © 2020. All Rights Reserved.